Turmeric as Treatment in Epilepsy



Status:Withdrawn
Conditions:Neurology, Neurology, Neurology, Epilepsy
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:1 - 70
Updated:5/2/2018
Start Date:March 2018
End Date:November 2018

Use our guide to learn which trials are right for you!

This is a single center open-label pilot clinical trial of patients 1-70 years of age with
greater than 6 seizures per month diagnosed with Dravet Syndrome, Lennox-Gastaut Syndrome,
Tuberous Sclerosis, or focal seizures. Twenty patients will be enrolled and treated with a
stable dose of orally administered turmeric oil daily for 3 months. Patients and caregivers
will be asked to keep a seizure diary logging all clinical events during the course of the
study. Serum comprehensive metabolic panel, complete blood count with differential, and
antiseizure medication levels, will be monitored at baseline, 1.5 months, and at the end of 3
months.


Inclusion Criteria:

- Patients with greater than greater than six seizures per month diagnosed with Dravet
Syndrome, Lennox-Gastaut Syndrome, Tuberous Sclerosis, or focal seizures followed at
NYU CEC.

Exclusion Criteria:

- Patients expected to have changes to any medications or supplements during study
period

- exposure to any investigational agent in the month prior to study entry

- pregnant or breast feeding women, positive pregnancy test

- history of non-compliance

- known drug or alcohol dependence

- known baseline hematologic

- liver function

- renal function

- absorption

- absorption
We found this trial at
1
site
550 1st Ave
New York, New York 10016
(212) 263-7300
Principal Investigator: Manisha Holmes, MD
Phone: 646-558-0877
New York University School of Medicine NYU School of Medicine has a proud history that...
?
mi
from
New York, NY
Click here to add this to my saved trials